7ÔÂ24ÈÕ£¬Öйú¿ÆÑ§Ôº¹ãÖÝÉúÎïÒ½Ò©Ó뽡¿µÑо¿ÔºÓ뻪ÇÈ´óѧ¼°¹ãÖÝÒ½¿Æ´óѧºÏ×÷ÔÚÕ¯¿¨²¡¶¾ÒßÃçÑо¿ÖÐÈ¡µÃнøÕ¹£¬Ïà¹Ø³É¹ûÒÔIncorporation of NS1 and prM/M are important to confer effective protection of adenovirus-vectored Zika virus vaccine carrying E protein ΪÌâÔÚÏß·¢±íÔÚNPJ Vaccines ÆÚ¿¯ÉÏ¡£ Õ¯¿¨²¡¶¾ÊôÓڻƲ¡¶¾¿Æ»Æ²¡¶¾Êô£¬Ö÷Ҫͨ¹ýÎÃý´«²¥¡£½üÄêÀ´£¬Õ¯¿¨²¡¶¾ÔÚÄÏÃÀ¡¢¶«ÄÏÑǵȵØÇø±¬·¢Á÷ÐУ¬ÒÑÔì³ÉÊý°ÙÍòÈ˸ÐȾ¡£ÎÒ¹úÔÚÄÏÃÀµÄÎñ¹¤ÈËÔ±Ò²ÊÇÎÒ¹úÊäÈëÐÔÕ¯¿¨¸ÐȾ²¡ÀýµÄÖ÷ÒªÀ´Ô´¡£ÁÙ´²·ÖÎöÏÔʾ£¬Õ¯¿¨²¡¶¾¸ÐȾÓëÐÂÉú¶ùСͷ֢¼°³ÉÄêÈ˸ñÁÖ-°ÍÀû×ÛºÏÖ¢µÈÉñ¾ÏµÍ³¼²²¡ÏÔÖøÏà¹Ø¡£¶¯ÎïʵÑéÖ¤Ã÷Õ¯¿¨²¡¶¾¿É¸ÐȾÄÔ²¿£¬Ëðº¦Éñ¾×éÖ¯£¬µ¼ÖÂСͷ֢¼°ÆäËüÖ¢×´¡£Òò´Ë£¬Õ¯¿¨²¡¶¾ÒѳÉΪȫÇò¹«¹²ÎÀÉúµÄÐÂÌôÕ½£¬µ«Ä¿Ç°ÉÐÎÞÅú׼ʹÓõÄÔ¤·ÀÒßÃç¡£ µ±Ç°Õ¯¿¨²¡¶¾ÒßÃçµÄÉè¼ÆÖ÷ÒªÒÔ°üĤµ°°×£¨envelope, E£©Îª¿¹Ô°Ð±ê£¬Ç°ÌåĤµ°°×£¨pre-membrane, prM£©×÷Ϊ°éµ°°×Ò²³£ÄÉÈëÒßÃçÉè¼Æ¡£·Ç½á¹¹µ°°×1£¨non-structual protein 1£¬NS1£©ËäÈ»ÔÚÕ¯¿¨²¡¶¾¸´ÖÆ¡¢Ö²¡ÖÐÆð¹Ø¼ü×÷Ó㬵«ÉÐÎÞÑо¿ÒÔÆä×÷Ϊ¿¹Ô°Ð±ê¡£¸ÃÑо¿ÖУ¬Ñо¿ÈËÔ±ÒÔ¸´ÖÆÈ±ÏÝÐÍ2ÐÍÏÙ²¡¶¾×÷ÎªÔØÌ壬̽Ë÷Á˽öЯ´øE£¬Ð¯´øprM¡¢E£¬Ð¯´øprM¡¢EÒÔ¼°NS1µÄÈýÖÖÒßÃç²ßÂÔ¡£½á¹û·¢ÏÖº¬NS1¿¹Ô×é·ÝµÄÒßÃç²ßÂÔ²»½öÔÚĸÊóÖÐÓÐЧµÖÓù²¡¶¾ÑªÖ¢£¬»¹Äܱ£»¤ÐÂÉúÊóÃâÊÜÕ¯¿¨²¡¶¾¸ÐȾµ¼ÖµÄÌåÖØ¼õÉÙ¡¢Éñ¾Ö¢×´µÈ£¬ÏÔÖøÒÖÖÆ²¡¶¾¶ÔÐÂÉúÊóµÄ¸ÐȾ¡£¸ÃÑо¿±íÃ÷prM¡¢NS1µÄÄÉÈë¿ÉÏÔÖøÌáÉýÃâÒß±£»¤Ð§¹û£¬ÌáʾNS1¿ÉÒÔ×÷Ϊկ¿¨²¡¶¾ÒßÃçµÄ¿¹Ô×é·Ý£¬ÖµµÃ½øÒ»²½ÆÀ¹ÀºÍ¿ª·¢¡£ »ªÇÈ´óѧ˶ʿÑо¿ÉúÁõÐËÁú¡¢¹ãÖÝÉúÎïԺ˶ʿÑо¿ÉúÒ¶ÏÍÃçºÍ²©Ê¿öÄÁÖ±øÎª¸ÃÂÛÎĵĹ²Í¬µÚÒ»×÷Õߣ¬Ñо¿Ô±³ÂÁè¡¢·ëÁ¢Ç¿£¨Çà´Ù»á»áÔ±£©Îª¸ÃÂÛÎĵĹ²Í¬Í¨Ñ¶×÷Õß¡£¸ÃÏîÑо¿µÃµ½Á˹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ð¡¢¹ú¼ÒÖØµãÑз¢¼Æ»®¡¢ÖпÆÔºÇàÄ괴дٽø»á¡¢¹ã¶«Ê¡Óë¹ãÖÝÊÐÏà¹Ø¿ÎÌâµÄ×ÊÖú¡£ 
|